Aging is driven by complex biological processes that gradually reduce the body’s ability to repair and regenerate tissues. One of the most important molecular regulators of aging is Sirtuin 1 (SIRT1), a protein that plays a central role in cellular repair, metabolism, and longevity.

In recent years, SIRT1 has gained significant attention in regenerative medicine and aesthetic science because of its ability to influence several key pathways involved in skin aging, mitochondrial function, DNA repair, and cellular regeneration.

Understanding how SIRT1 works provides insight into the biological mechanisms behind healthy aging and advanced skin rejuvenation treatments.

SIRT1 (Sirtuin 1) is a NAD⁺-dependent enzyme belonging to the sirtuin family of proteins, which regulate many of the cellular processes involved in aging.

SIRT1 functions primarily as a histone deacetylase, meaning it regulates gene expression by modifying proteins that control DNA accessibility. Through this activity, SIRT1 influences important cellular processes such as:

• DNA repair
• mitochondrial function
• metabolic regulation
• inflammation control
• cellular stress resistance

Because SIRT1 requires nicotinamide adenine dinucleotide (NAD⁺) to function, its activity is directly linked to cellular energy metabolism.

Research has shown that NAD⁺ levels decline significantly with age, which leads to reduced SIRT1 activity and contributes to many of the biological changes associated with aging. (Imai & Guarente, 2014)

SIRT1 activity depends on the availability of NAD⁺, an essential coenzyme present in every cell of the body.

During the SIRT1 enzymatic reaction, NAD⁺ is consumed to remove acetyl groups from regulatory proteins, producing nicotinamide and O-acetyl-ADP-ribose.

Because of this biochemical relationship, declining NAD⁺ levels directly reduce SIRT1 activity, impairing many cellular processes that protect against aging.

Age-related NAD⁺ depletion occurs due to several factors, including:

• increased DNA damage and PARP activation
• reduced NAD⁺ biosynthesis
• increased NAD⁺ consumption by enzymes such as CD38

This decline disrupts cellular homeostasis and contributes to the hallmarks of aging, including mitochondrial dysfunction, genomic instability, and chronic inflammation. (Zhang & Sauve, 2018)

SIRT1 regulates several pathways involved in the biological processes that drive aging.

These include mitochondrial health, cellular senescence, DNA repair, metabolic regulation, and inflammatory signalling.

Mitochondrial dysfunction is one of the most important drivers of aging and age-related disease.

SIRT1 helps maintain mitochondrial health by activating PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1 alpha), a transcriptional regulator responsible for mitochondrial biogenesis.

Activation of PGC-1α promotes:

• increased mitochondrial production
• improved oxidative metabolism
• enhanced cellular energy production

SIRT1 also supports mitophagy, the process by which damaged mitochondria are removed from cells.

This process prevents the accumulation of dysfunctional mitochondria that generate excessive reactive oxygen species (ROS), a major contributor to cellular aging. (Yuan et al., 2016)

Cellular senescence occurs when cells permanently stop dividing and begin secreting inflammatory factors that damage surrounding tissue.

These senescent cells accumulate with age and contribute to tissue degeneration, chronic inflammation, and impaired regeneration.

SIRT1 helps suppress cellular senescence through several mechanisms.

Research has shown that SIRT1:

• reduces expression of the senescence marker p16INK4A
• delays senescence-associated β-galactosidase activity
• reduces formation of senescence-associated heterochromatin foci

SIRT1 can also promote the expression of human telomerase reverse transcriptase (hTERT), which supports telomere maintenance and helps delay replicative senescence (Huang et al., 2008; Yamashita et al., 2012)

Maintaining genomic stability is essential for healthy aging.

SIRT1 participates in multiple DNA repair pathways that protect cells from genetic damage.

For example, SIRT1 deacetylates Ku70, a protein involved in repairing double-strand DNA breaks. It also interacts with PARP1, another enzyme responsible for detecting and repairing DNA damage.

However, both SIRT1 and PARP1 require NAD⁺ to function properly. When NAD⁺ levels decline with age, DNA repair mechanisms become less efficient, allowing damage to accumulate.

This progressive genomic instability contributes to aging and increased disease risk (Mendelsohn & Larrick, 2017).

Chronic low-grade inflammation is another key driver of aging, a process often referred to as inflammaging.

SIRT1 plays an important role in controlling inflammatory signalling pathways.

One of its primary targets is NF-κB, a transcription factor that regulates inflammatory cytokine production.

SIRT1 suppresses NF-κB activity by deacetylating its p65 subunit, reducing the expression of inflammatory molecules such as:

• tumour necrosis factor-alpha (TNF-α)
• interleukin-6 (IL-6)

By limiting inflammatory signalling, SIRT1 helps protect tissues from chronic inflammation and age-related degeneration. (Sung et al., 2021)

The skin is particularly vulnerable to aging due to constant exposure to environmental stressors such as ultraviolet radiation and pollution.

These stressors generate oxidative damage, reduce collagen production, and impair cellular repair mechanisms.

SIRT1 plays an important protective role in skin biology by regulating several pathways involved in skin regeneration.

In dermal fibroblasts, SIRT1 activity helps:

• promote collagen production
• improve mitochondrial function
• reduce oxidative stress
• suppress inflammatory signalling

Studies have shown that SIRT1 activation can protect skin cells from UV-induced damage and premature cellular aging.

Reduced SIRT1 activity in aging skin is associated with increased oxidative stress, impaired collagen synthesis, and reduced regenerative capacity (Sung et al., 2021)

Beyond its role in skin aging, SIRT1 also regulates several metabolic pathways linked to longevity.

SIRT1 improves metabolic function by:

• enhancing insulin sensitivity
• promoting fatty acid oxidation
• improving glucose metabolism

These metabolic benefits help maintain energy balance and reduce the risk of age-related diseases. (Nogueiras et al., 2012)

Research into SIRT1 and NAD⁺ metabolism continues to expand rapidly.

Many scientists now consider NAD⁺ decline and reduced sirtuin activity to be central drivers of aging.

By restoring NAD⁺ levels and supporting SIRT1 activity, future therapies may help slow or even partially reverse some aspects of cellular aging.

This growing field of research is helping shape the future of regenerative medicine and advanced anti-aging treatments, including therapies designed to support skin regeneration and long-term cellular health.

SIRT1 is one of the most important molecular regulators of aging discovered to date.

By controlling pathways involved in DNA repair, mitochondrial function, inflammation, and cellular metabolism, SIRT1 plays a critical role in maintaining cellular health and resilience.

However, age-related declines in NAD⁺ levels reduce SIRT1 activity, contributing to many of the biological processes associated with aging.

Understanding the NAD⁺–SIRT1 axis provides valuable insight into the mechanisms behind aging and the development of next-generation regenerative therapies designed to support healthier aging and improved skin vitality.

Imai S., Guarente L. (2014). NAD⁺ and sirtuins in aging and disease. Trends in Cell Biology.

Zhang N., Sauve A.A. (2018). Regulatory effects of NAD metabolic pathways on sirtuin activity. Progress in Molecular Biology and Translational Science.

Yuan Y. et al. (2016). Regulation of SIRT1 in aging: roles in mitochondrial function and biogenesis. Mechanisms of Ageing and Development.

Huang J. et al. (2008). SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6K1 signaling in human fibroblasts. PLoS One.

Yamashita S. et al. (2012). SIRT1 prevents replicative senescence by potentiating transcription of human telomerase reverse transcriptase. Biochemical and Biophysical Research Communications.

Mendelsohn A.R., Larrick J.W. (2017). The NAD+/PARP1/SIRT1 axis in aging. Rejuvenation Research.

Sung J.Y. et al. (2021). SIRT1 suppresses cellular senescence and inflammatory cytokine release in human dermal fibroblasts. Experimental Gerontology.

Nogueiras R. et al. (2012). Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiological Reviews.

Kane A.E., Sinclair D.A. (2018). Sirtuins and NAD in the development and treatment of metabolic and cardiovascular diseases. Circulation Research.